Tempest Therapeutics Analyst Ratings
Tempest Therapeutics Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/11/2023 | 5637.7% | HC Wainwright & Co. | → $35 | Reiterates | Buy → Buy |
| 06/05/2023 | 5637.7% | HC Wainwright & Co. | → $35 | Reiterates | Buy → Buy |
| 05/30/2023 | 5637.7% | HC Wainwright & Co. | → $35 | Reiterates | Buy → Buy |
| 05/11/2023 | 5637.7% | HC Wainwright & Co. | → $35 | Reiterates | Buy → Buy |
| 04/28/2023 | 2195.08% | Ladenburg Thalmann | $8 → $14 | Maintains | Buy |
| 03/23/2023 | 883.61% | Piper Sandler | $10 → $6 | Maintains | Overweight |
| 03/23/2023 | 5637.7% | HC Wainwright & Co. | → $35 | Reiterates | → Buy |
| 02/08/2023 | 5637.7% | HC Wainwright & Co. | → $35 | Maintains | Buy |
| 09/15/2022 | 1211.48% | Ladenburg Thalmann | → $8 | Initiates Coverage On | → Buy |
| 05/16/2022 | 5637.7% | HC Wainwright & Co. | $51 → $35 | Maintains | Buy |
| 10/21/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 07/13/2021 | 8260.66% | HC Wainwright & Co. | → $51 | Initiates Coverage On | → Buy |
| 07/06/2021 | 3670.49% | Piper Sandler | → $23 | Initiates Coverage On | → Overweight |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/11/2023 | 5637.7% | HC Wainwright & Co. | → 35 美元 | 重申 | 购买 → 购买 |
| 06/05/2023 | 5637.7% | HC Wainwright & Co. | → 35 美元 | 重申 | 购买 → 购买 |
| 05/30/2023 | 5637.7% | HC Wainwright & Co. | → 35 美元 | 重申 | 购买 → 购买 |
| 05/11/2023 | 5637.7% | HC Wainwright & Co. | → 35 美元 | 重申 | 购买 → 购买 |
| 04/28/2023 | 2195.08% | 拉登堡塔尔曼 | 8 美元 → 14 美元 | 维护 | 购买 |
| 03/23/2023 | 883.61% | 派珀·桑德勒 | 10 美元 → 6 美元 | 维护 | 超重 |
| 03/23/2023 | 5637.7% | HC Wainwright & Co. | → 35 美元 | 重申 | → 购买 |
| 02/08/2023 | 5637.7% | HC Wainwright & Co. | → 35 美元 | 维护 | 购买 |
| 2022 年 9 月 15 日 | 1211.48% | 拉登堡塔尔曼 | → 8 美元 | 启动覆盖开启 | → 购买 |
| 05/16/2022 | 5637.7% | HC Wainwright & Co. | 51 美元 → 35 美元 | 维护 | 购买 |
| 2021 年 10 月 21 日 | — | 威廉布莱尔 | 启动覆盖开启 | → 跑赢大盘 | |
| 2021 年 7 月 13 日 | 8260.66% | HC Wainwright & Co. | → 51 美元 | 启动覆盖开启 | → 购买 |
| 2021 年 6 月 7 日 | 3670.49% | 派珀·桑德勒 | → 23 美元 | 启动覆盖开启 | → 超重 |
What is the target price for Tempest Therapeutics (TPST)?
Tempest Therapeutics（TPST）的目标价格是多少？
The latest price target for Tempest Therapeutics (NASDAQ: TPST) was reported by HC Wainwright & Co. on August 11, 2023. The analyst firm set a price target for $35.00 expecting TPST to rise to within 12 months (a possible 5637.70% upside). 9 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 于2023年8月11日公布了Tempest Therapeutics（纳斯达克股票代码：TPST）的最新目标股价。这家分析公司将目标股价定为35.00美元，预计TPST将在12个月内升至5637.70％（可能上涨5637.70％）。去年有9家分析公司公布了评级。
What is the most recent analyst rating for Tempest Therapeutics (TPST)?
分析师对Tempest Therapeutics（TPST）的最新评级是多少？
The latest analyst rating for Tempest Therapeutics (NASDAQ: TPST) was provided by HC Wainwright & Co., and Tempest Therapeutics reiterated their buy rating.
Tempest Therapeutics（纳斯达克股票代码：TPST）的最新分析师评级由HC Wainwright & Co. 提供，Tempest Therapeutics重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for Tempest Therapeutics (TPST)?
Tempest Therapeutics（TPST）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tempest Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tempest Therapeutics was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与Tempest Therapeutics的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。Tempest Therapeutics的最后一次评级是在2023年8月11日提交的，因此你应该预计下一个评级将在2024年8月11日左右公布。
Is the Analyst Rating Tempest Therapeutics (TPST) correct?
分析师对 Tempest Therapeutics (TPST) 的评级正确吗？
While ratings are subjective and will change, the latest Tempest Therapeutics (TPST) rating was a reiterated with a price target of $0.00 to $35.00. The current price Tempest Therapeutics (TPST) is trading at is $0.61, which is within the analyst's predicted range.
尽管评级是主观的，将会发生变化，但最新的Tempest Therapeutics（TPST）评级得到了重申，目标股价为0.00美元至35.00美元。Tempest Therapeutics（TPST）目前的交易价格为0.61美元，在分析师的预测区间内。